|
1
|
Trikudanathan S: Polycystic ovarian
syndrome. Med Clin North Am. 99:221–235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bostancı MS, Akdemir N, Cinemre B,
Cevrioglu AS, Özden S and Ünal O: Serum irisin levels in patients
with polycysticovary syndrome. Eur Rev Med Pharmacol Sci.
19:4462–4468. 2015.PubMed/NCBI
|
|
3
|
Al-Zubeidi H and Klein KO: Randomized
clinical trial evaluating metformin versus oral contraceptive pills
in the treatment of adolescents with polycystic ovarian syndrome. J
Pediatr Endocrinol Metab. 28:853–858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yakubov Y and Mandel L: Bilateral parotid
swelling in polycystic ovarian syndrome. J Oral Maxillofac Surg.
74:991–994. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang B1, Sun ZJ, Chen B, Zhang J, Zhao H,
Li CW, Cao YK and Cao F: Statin ameliorates endothelial dysfunction
and insulin resistance in Tibet women with polycystic ovary
syndrome. Eur Rev Med Pharmacol Sci. 20:1185–1191. 2016.PubMed/NCBI
|
|
6
|
Silfeler Benk D, Kurt Keskin R, Kaya OA,
Yengil E, Hamamci B, Okyay AG and Beyazit A: Demodex folliculorum
in polycystic ovary syndrome patients. Eur Rev Med Pharmacol Sci.
19:1141–1145. 2015.PubMed/NCBI
|
|
7
|
Ting W, Yanyan Q, Jian H, Keqin H and Duan
M: The relationship between insulin resistance and CpG island
methylation of LMNA gene in polycystic ovary syndrome. Cell Biochem
Biophys. 67:1041–1047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gondro C: Genome wide association
studiesPrimer to Analysis of Genomic Data Using R. Springer
International Publishing; Cham, Switzerland: pp. 73–103. 2015,
View Article : Google Scholar
|
|
9
|
Zhou X and Stephens M: Efficient
algorithms for multivariate linear mixed models in genome-wide
association studies. Nat Methods. 11:407–409. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou PP, Li Y, Ma ZD, Li ZY, Chen FY and
Jiang YX: Single nucleotide polymorphisms in the promoter region of
mir-133a-1 and in pre-mir-152 rs1707 may contribute to the risk of
asthma in a Chinese Han population. Eur Rev Med Pharmacol Sci.
20:2642–2649. 2016.PubMed/NCBI
|
|
11
|
Taşan M, Musso G, Hao T, Vidal M, MacRae
CA and Roth FP: Selecting causal genes from genome-wide association
studies via functionally coherent subnetworks. Nat Methods.
12:154–159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lerchbaum E, Schwetz V, Giuliani A and
Obermayer-Pietsch B: Assessment of glucose metabolism in polycystic
ovary syndrome: HbA1c or fasting glucose compared with the oral
glucose tolerance test as a screening method. Hum Reprod.
28:2537–2544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Legro RS, Arslanian SA, Ehrmann DA, Hoeger
KM, Murad MH, Pasquali R and Welt CK: Endocrine Society: Diagnosis
and treatment of polycystic ovary syndrome: An Endocrine Society
clinical practice guideline. J Clin Endocrinol Metab. 98:4565–4592.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Belosi C, Selvaggi L, Apa R, Guido M,
Romualdi D, Fulghesu AM and Lanzone A: Is the PCOS diagnosis solved
by ESHRE/ASRM 2003 consensus or could it include ultrasound
examination of the ovarian stroma? Hum Reprod. 21:3108–3115. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ecklund LC and Usadi RS: Endocrine and
reproductive effects of polycystic ovarian syndrome. Obstet Gynecol
Clin North Am. 42:55–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abbott DH, Nicol LE, Levine JE, Xu N,
Goodarzi MO and Dumesic DA: Nonhuman primate models of polycystic
ovary syndrome. Mol Cell Endocrinol. 373:21–28. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li R, Zhang Q, Yang D, Li S, Lu S, Wu X,
Wei Z, Song X, Wang X, Fu S, et al: Prevalence of polycystic ovary
syndrome in women in China: A large community-based study. Hum
Reprod. 28:2562–2569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bili E, Dampala K, Iakovou I, Tsolakidis
D, Giannakou A and Tarlatzis BC: The combination of ovarian volume
and outline has better diagnostic accuracy than prostate-specific
antigen (PSA) concentrations in women with polycystic ovarian
syndrome (PCOs). Eur J Obstet Gynecol Reprod Biol. 179:32–35. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mutharasan P, Galdones E, Bernabé Peñalver
B, Garcia OA, Jafari N, Shea LD, Woodruff TK, Legro RS, Dunaif A
and Urbanek M: Evidence for chromosome 2p16.3 polycystic ovary
syndrome susceptibility locus in affected women of European
ancestry. J Clin Endocrinol Metab. 98:E185–E190. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Glueck CJ, Woo JG, Khoury PR, Morrison JA,
Daniels SR and Wang P: Adolescent oligomenorrhea (age 14–19) tracks
into the third decade of life (age 20–28) and predicts increased
cardiovascular risk factors and metabolic syndrome. Metabolism.
64:539–553. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bassiouny YA, Rabie WA, Hassan AA and
Darwish RK: Association of the luteinizing
hormone/choriogonadotropin receptor gene polymorphism with
polycystic ovary syndrome. Gynecol Endocrinol. 30:428–430. 2014.
View Article : Google Scholar : PubMed/NCBI
|
